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A newly recognized rickettsial disease,
human ehrlichiosis is emerging in tick-infested
areas. First described in the United States (1),
the disease, in both monocytic and granulocytic
forms, is usually found where Lyme disease is
endemic (2,3). Sporadic cases of ehrlichiosis
have been reported in  southern and northern
Europe. Recently, cases were reported in
Slovenia, not far from the Italian border (4).
Preliminary studies show that 17.1%, 5%,
6.3%, and 11.4% of forestry workers in
Switzerland, United Kingdom, Italy, and
Sweden, respectively (5-8), have antibodies to
Ehrlichia (E. phagocytophila and E. equi).
Ehrlichiosis in Southern Italy
In 1995 through 1996, four U.S. citizens (two
boys and two women) living on a U.S. Navy base
in Sardinia (La Maddalena) became ill with acute
fever, headache, malaise, and cytopenia  after a
tick bite. Once rickettsial disease was excluded
(Sardinia is a boutonneuse feverendemic focus),
ehrlichia infection was suspected. Coupled
serum samples (S1 and S2 a week apart) from
each patient were processed by immunofluores-
cence assay (IFA). All S1 were negative for both
species of Ehrlichia, while three S2 were positive
for immunoglobulin (Ig) M (1:128) to E. chaffeensis
and negative for IgG (Table), meeting the case
definition criteria for ehrlichiosis (Olson, pers.
comm.). Subsequently, seven cases of ehrlichiosis-
like illness following a tick bite were reported in
Sardinian residents. The cases were not
confirmed by serologic tests in Rome and Atlanta
(E. Lillini, unpub. data).
Ehrlichiosis in Alpine Areas of Italy
In the last 10 years, tick-borne diseases,
especially Lyme disease and tick-borne encepha-
litis (TBE), have become more widespread in
Alpine mountain areas (9). Although new
diagnostic tests aid clinical diagnosis, some
febrile illnesses in persons bitten by ticks remain
unexplained. Human ehrlichiosis must now be
considered an emerging problem in tick-infested
areas. Pioneering studies in the northern Veneto
region (7,10) have recorded Ehrlichia antibodies
in residents of the Alpine area, where Ixodes
ticks are present and Lyme disease appears
widespread (with more than 500 clinical cases
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Immunoglobulin M seroconversion to Ehrlichia chaffeensis was documented in
U.S. citizens bitten by ticks in Sardinia. Seven cases of suspected ehrlichiosis in local
residents were not confirmed by laboratory tests. In Alpine areas antibodies to E.
phagocytophila were detected in persons at high risk, i.e., foresters (8.6%) and hunters
(5.5%), and in controls (l.5%). Of 153 persons bitten by ticks, only one was Ehrlichia
antibody-positive after 6 months.
Table. Immunoglobulin (Ig) M antibodies to Ehrlichia
chaffeensis in four U.S. citizens bitten by ticks in
Sardinia (La Maddalena)
Date of No.
Case onset S1 weeks S2
8-yr-old boya 8/95 Neg 1 1:128
12-yr-old boy 7/96 Neg 1 1:64b
25-yr-old woman 7/96 Neg 1 1:128
24-yr-old woman 7/96 Neg 1 1:128c
aEvacuated to U.S. Army Hospital in Landsthul, Germany.
bNot diagnostically significant.
c Third IgM control 1 month later = 1:256.664 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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reported annually). This study included Cadore,
Bellunese (Veneto region), and Trento Districts,
neighboring zones located around an area of 80
to 100 miles in the upper northeastern Alpine
region (Figure), which pose equal risk of
acquiring tick-borne pathogens.
In 1995 through 1996, 544 serum samples
were collected from inhabitants of the northeast-
ern Alpine area presumably at risk for
ehrlichiosis because they lived in wooded areas
and spent time outdoors. A simplified classifica-
tion system subdivided the participants accord-
ing to job or primary vocation: healthy residents
(controls, n = 193), rangers and forestry workers
from Belluno Regional Park and Forestry
Services of Trento District (n = 242), and hunters
(n = 109) from both areas. Ehrlichia IgG
antibodies were detected by IFA using E.
phagocytophilainfected ovine neutrophils as
antigen (courtesy of Dr. K.J. Sumption, Royal
School of Veterinary Studies, Edinburgh
University, UK). An IFA titer ³ 1:80 was
considered positive (all analyses contained
controls of conjugate antibodies and positive and
negative sera). Antibodies to Borrelia burgdorferi
sensu lato were routinely detected by a
commercial standard immunoenzyme test kit
(Behring, Marburg, Germany). IgG and IgM
were considered positive at values (optical
density) of >0.6 for IgG and >0.50 for IgM. The
TBE antibody (positive titer ³ 150) was
performed by immunozyme and confirmed by
immunoblot (Immuno AG, Wien, Austria). This
retrospective serologic study of a cohort of
persons at high risk showed an IFA positivity
(without benefit of immunoblot confirmation) to
E. phagocytophila (highest titer 1:160) in 21
(8.6%) of 242 foresters, 6 (5.5%) of 109 hunters,
and 3 (1.5%) of 193 controls, without significant
difference between the three wooded areas
studied. Concerning the Borrelia positivity, the
mean prevalence value among the 541 persons
tested was 14.6%, with a lower value (10%) in
foresters from Trento District. Seropositivity
was most frequent in persons ages 40 to 60
years.
In summer and autumn of 1997, we followed
for 6 months 153 Cadore residents bitten by
ticks; we detected Borrelia, Ehrlichia, and TBE
antibodies immediately after the tick bite and 2
and 6 months later. At the preliminary
examination, serologic evidence indicated expo-
sure to multiple tick-borne agents in 26
(16.9%) of 153 patients, 15% to Borrelia,
0.6% to E. phagocytophila, 1.3% to TBE
virus. At 2 months, four of the 131 patients
tested had IgM antibodies to Borrelia (overall
incidence 3%); two of these had a clinical pattern
of borreliosis. The mean IgG titer to Borrelia was
46 (range 7 to >375); the IgM titers were 0.511 to
>1.892. Concomitantly, one patient showed
typical clinical features of TBE infection,
followed by a diagnostic IgM and IgG titer
rise (>400); a febrile flulike illness in
another patient remained undiagnosed. In
the only E. phagocytophilapositive person, the
titer remained unchanged (1:80). Among the 128
patients tested at 6 months, the four previously
recorded as IgM positive to Borrelia were
confirmed with increased titers (>1,892), and a
concomitant IgG positivity (titer >375) was
observed in one of these four cases. This study
may be one of the largest prospective serologic
evaluations for tick-borne pathogens; previous
studies have been single-sample serosurveys.
Our data confirm the well-documented high
incidence of Borrelia infections in upper Alpine
areas and show remarkably lower antibody
prevalence rates (1%) for TBE and Ehrlichia.
The different values observed between foresters
and healthy controls (8.6% versus 1.5%; p
<0.050) from the same zones could be justified by
different lifestyles. Foresters spent most of their
time in potentially infected areas, changing
worksites daily, coming into frequent contact
with ticks, and reporting one or more tickbites
per year. Controls, on the contrary, had limited
outdoor activity, generally restricted to the vicinity
of their homes, and less contact with ticks.
Figure. Areas under study, Sardinia and northeastern
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Seroconversion to either Borrelia or TBE
virus were strongly associated with a history of
tick attachment; this association and the origin
of the persons from a Lyme diseaseendemic
area support the likelihood that the observed
seroconversions were due to a tick-borne agent.
The local residents, mainly living in small
villages, have close contact with nature but often
do not remember tick bites, perhaps because
ticks are small and may remain attached for a
long time without being noticed. In fact, in
approximately 30% of the Lyme disease patients,
tick bites are not detectable or reported;
consequently, it is difficult to divide these
persons into well-defined groups according to
tick bite history (9).
Since Lyme disease and ehrlichiosis are
zoonoses transmitted by the same tick species
(Ixodes) and perpetuated in the same reservoir
(rodents, deers, sheep), human infections by
these pathogens are likely to occur in the same
wooded environments. Hunters and rangers,
who frequently come in direct contact with
animal (deer) carcasses infested by Ixodes ticks,
or who camp overnight, are at high risk for tick-
borne infections (9). Hunters may be infected
directly by deer blood (11). Ehrlichia seropositiv-
ity in persons at risk suggests that mild or
subclinical illness due to an infection by
Ehrlichia species is possible, as recently
confirmed (Caruso and Brouqui, pers. data).
The low titers observed until now (maximum
1:160) are probably related to a past, mild
infection or to the use of an antigen with low
specificity.
Conclusions
Our findings indicate the presence of
ehrlichiosis in southern Italy (Sardinia) and of
subclinical infections in the upper Alpine
northeastern areas. In these forested areas,
where most patients and physicians are still
unaware of the disease, clinical cases of
ehrlichiosis had not been documented, although
we can presume that some cases of unexplained
febrile illness, especially in areas where Lyme
disease is endemic, could be related to Ehrlichia
infection. Further epidemiologic surveillance
and controls, now in progress, may better clarify
the emergence of this new infection in Italy.
Dr. Nuti is associate professor of tropical and infec-
tious diseases at the La Sapienza University of Rome.
His research has focused on leprosy, viral hepatitis, ma-
laria, dengue, Hantaan virus, and tick-borne diseases.
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